Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chỉ hiển thị Multimedia

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
bởiStephen Padilla
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
Prompt DOAC therapy after stroke safe for AF patients
11 Nov 2024
bởiJairia Dela Cruz
Initiating direct oral anticoagulants (DOACs) within 4 days after an ischaemic stroke in patients with atrial fibrillation (AF) is safe and yields similar outcomes as delayed initiation, as shown in the phase 4 OPTIMAS trial.







